Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to Michael H. Davidson

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Davidson, Michael H.

Item TypeName
Concept Cardiovascular Diseases
Academic Article Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.
Academic Article Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women.
Academic Article Efficacy of over-the-counter nutritional supplements.
Academic Article Risk of cardiovascular disease and sudden death in schizophrenia.
Academic Article Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
Academic Article A cross-sectional study of lipids and ApoC levels in Alzheimer's patients with and without cardiovascular disease.
Academic Article C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: the Strong Heart Study.
Academic Article Global risk management in patients with type 2 diabetes mellitus.
Academic Article Use of a treatment algorithm to achieve NCEP ATP III goals with atorvastatin.
Academic Article Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial.
Academic Article Effects of a reduced-glycemic-load diet on body weight, body composition, and cardiovascular disease risk markers in overweight and obese adults.
Academic Article Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications.
Academic Article Effects of high-fiber oat and wheat cereals on postprandial glucose and lipid responses in healthy men.
Academic Article Application of recent definitions of the metabolic syndrome to survey data from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE II).
Academic Article Should every patient with diabetes receive a statin?
Academic Article The editor's roundtable: lipid management beyond statins-reducing residual cardiovascular risk.
Academic Article Overview of prevention and treatment of atherosclerosis with lipid-altering therapy for pharmacy directors.
Academic Article Combination therapy in the management of complex dyslipidemias.
Academic Article Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation.
Academic Article The editor's roundtable: the JUPITER trial--initial results and clinical implications.
Academic Article ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): developed in collaboration with the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabili...
Academic Article A genetic and epidemiologic study of cardiovascular disease in Alaska natives (GOCADAN): design and methods.
Academic Article Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction.
Academic Article Effect of ACAT inhibition on the progression of coronary atherosclerosis.
Academic Article Low high-density lipoprotein cholesterol and increased cardiovascular disease risk: an analysis of statin clinical trials.
Academic Article Underappreciated opportunities for low-density lipoprotein management in patients with cardiometabolic residual risk.
Academic Article Targeting high-density lipoprotein cholesterol in the management of cardiovascular disease.
Academic Article Usefulness of increased skin cholesterol to identify individuals at increased cardiovascular risk (from the Predictor of Advanced Subclinical Atherosclerosis study).
Academic Article Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation.
Academic Article Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines.
Academic Article High-dose statin therapy: benefits and safety in aggressive lipid lowering.
Academic Article Statin and ezetimibe combination therapy in cardiovascular disease.
Academic Article Flushing profile of extended-release niacin/laropiprant versus gradually titrated niacin extended-release in patients with dyslipidemia with and without ischemic cardiovascular disease.
Academic Article Counterpoint: Low-density lipoprotein cholesterol goals in patients with diabetes are adequately based on evidence.
Academic Article High-density lipoproteins: marker of cardiovascular risk and therapeutic target.
Academic Article Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists.
Academic Article Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker.
Academic Article The use of high-sensitivity assays for C-reactive protein in clinical practice.
Academic Article Efficacy and safety of dalcetrapib in type 2 diabetes mellitus and/or metabolic syndrome patients, at high cardiovascular disease risk.
Academic Article Cardio-diabetes: special considerations for the patient with diabetes and cardiovascular disease. Introduction.
Academic Article Cardiovascular risk factors in a patient with diabetes mellitus and coronary artery disease: therapeutic approaches to improve outcomes: perspectives of a preventive cardiologist.
Academic Article Type 2 diabetes and cardiovascular disease: reducing the risk.
Academic Article Apolipoprotein measurements: is more widespread use clinically indicated?
Academic Article ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): developed in collaboration with the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabili...
Academic Article Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
Academic Article The incremental value of lipids and inflammatory biomarkers in determining residual cardiovascular risk.
Academic Article Treatment of the elderly with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors: focus on drug interactions.
Academic Article Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment.
Academic Article The role of cardiovascular risk factors in Alzheimer's disease.
Academic Article Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.
Academic Article Cardiovascular disease among Alaska Natives: a review of the literature.
Academic Article Impaired diurnal blood pressure variation and all-cause mortality.
Academic Article Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease?
Academic Article Low-density lipoprotein cholesterol, non-high-density lipoprotein, apolipoprotein, or low-density lipoprotein particle: what should clinicians measure?
Academic Article Changes in cardiovascular risk associated with phentermine and topiramate extended-release in participants with comorbidities and a body mass index =27 kg/m(2).
Academic Article Diagnosis and treatment of familial hypercholesterolaemia.
Academic Article AACE comprehensive diabetes management algorithm 2013.
Academic Article Underappreciated opportunities for high-density lipoprotein particles in risk stratification and potential targets of therapy.
Academic Article Combination therapy with statins: who benefits?
Academic Article Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease.
Academic Article High-density lipoproteins: a consensus statement from the National Lipid Association.
Academic Article Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.
Academic Article A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial).
Academic Article [Official document of the International Society of Atherosclerosis: general recommendations for treatment of dyslipidemia. Executive summary].
Academic Article Potential impact of dipeptidyl peptidase-4 inhibitors on cardiovascular pathophysiology in type 2 diabetes mellitus.
Academic Article Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.
Academic Article Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial.
Academic Article Role of Ezetimibe in Lipid-Lowering and Cardiovascular Disease Prevention.
Academic Article Triglyceride-lowering therapies reduce cardiovascular disease event risk in subjects with hypertriglyceridemia.
Academic Article AACE/ACE comprehensive diabetes management algorithm 2015.
Academic Article Using Discordance in Monozygotic Twins to Understand Causality of Cardiovascular Disease Risk Factors.
Academic Article Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control.
Academic Article Omega-3 carboxylic acids monotherapy and combination with statins in the management of dyslipidemia.
Academic Article AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARYComplete Appendix to Guidelines available at http://journals.aace.com.
Academic Article The effect of omega-3 carboxylic acids on apolipoprotein CIII-containing lipoproteins in severe hypertriglyceridemia.
Academic Article AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
Academic Article Evolution of Omega-3 Fatty Acid Therapy and Current and Future Role in the Management of Dyslipidemia.
Academic Article Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial.
Academic Article Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial.
Academic Article Lower On-Treatment Low-Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials.
Academic Article How Genomics Is Personalizing the Management of Dyslipidemia and Cardiovascular Disease Prevention.
Academic Article Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials).
Academic Article ?-6 Polyunsaturated Fatty Acids and Cardiometabolic Health: Current Evidence, Controversies, and Research Gaps.
Academic Article Clinical trials.
Academic Article Lipoprotein(a) reductions from PCSK9 inhibition and major adverse cardiovascular events: Pooled analysis of alirocumab phase 3 trials.
Academic Article Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control.
Academic Article Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.
Academic Article Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary.

Search Criteria
  • Cardiovascular Disease